Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

CNS Pharmaceuticals, Inc.

NASDAQ: CNSP · Life Sciences · 2 alerts · CIK 1729427

Share price
$3.48Close, Nov 16
Market cap
$5.14M
Shares outstanding
1.48MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All CNS Pharmaceuticals, Inc. filings on SEC EDGAR ↗

7:31 AM ET 10-Q
Financial Results

CNS Pharmaceuticals Q3 2026 Results: Net Loss of $2.5M, Loss Narrows

CNS Pharmaceuticals reported a net loss of $10.0 million for the nine months ended September 30, 2026, while significantly strengthening its cash position to $17.2 million following a $22.5 million private placement in May 2026. The company is currently pivoting its corporate strategy toward acquiring new therapeutic assets and exploring out-licensing opportunities for its legacy glioblastoma programs.

Key figure
Net loss $2.5M
8:00 AM ET 8-K
Shareholder Meeting

CNS Pharmaceuticals Shareholder Meeting

CNS Pharmaceuticals held its 2026 Annual Meeting of Stockholders on September 30, 2026, where shareholders elected six directors and ratified MaloneBailey, LLP as the independent auditor. Stockholders also approved an amendment to the 2020 Equity Plan to increase the number of authorized shares by 650,000 and approved executive compensation on an advisory basis.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.